Latest Breaking News On - Ajai chari - Page 1 : vimarsana.com

FDA approves Tecvayli for advanced multiple myeloma

FDA approves Tecvayli for advanced multiple myeloma
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Mark leiserLee greenbergerIcahn school of medicine at mount sinaiLeukemia lymphoma societyJanssen biotechAjai chariIcahn schoolMount sinaiLymphoma society

Top 5 Most-Read Evidence-Based Oncology™ Articles in 2023

Articles highlighting links between COVID-19 and cancer were among the most-read in Evidence-Based Oncology™ in 2023.

United statesSouth carolinaMark stadlerSach jainKashyap patelAfshin beheshtiJohn tomtishenCancer care associatesInternational research teamCarrum healthAmes research centerAmerican society of hematology annual meeting expositionHealth system to last for yearsEvidence based oncologyGrowing demandExpand access

Talquetamab Dose Modifications May Lower AEs While Maintaining Efficacy in R/R Multiple Myeloma

Dose modifications of talquetamab improved on-target adverse effects while maintaining responses for patients with relapsed/refractory multiple myeloma.

United statesSan franciscoTalquetamab talveyHelen diller family comprehensive cancer centerAmerican society of hematology annual meetingUniversity of californiaMyeloma programHematology annualAjai chariMultiple myeloma programDiller family comprehensive cancer

New Analyses Demonstrate Versatility and Continued Efficacy of TALVEY™ in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

/PRNewswire/ Johnson & Johnson announced today an analysis from the Phase 1/2 MonumenTAL-1 study of TALVEY™ (talquetamab-tgvs) in patients with relapsed or.

United statesSan franciscoChristie corbettSatu glaweChristoph heuckAmerican society of hematologyNone of janssen research developmentHematology clinical developmentEuropean commissionJanssen research developmentEastern cooperative oncology groupJanssen biotech incUniversity of californiaMyeloma programInternational myeloma working groupExchange commission

Reduced talquetamab dose intensity maintains efficacy, may lessen toxicities in myeloma

Reduced talquetamab dose intensity maintains efficacy, may lessen toxicities in myeloma
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoTalquetamab janssenUniversity of californiaAjai chari